The estimated Net Worth of Peter J Wilkinson is at least $1.97 millió dollars as of 29 April 2024. Mr. Wilkinson owns over 2,439 units of Labcorp stock worth over $455,571 and over the last 5 years he sold LH stock worth over $1,511,948. In addition, he makes $0 as Senior Vice President és Chief Accounting Officer at Labcorp.
Peter has made over 19 trades of the Labcorp stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 2,439 units of LH stock worth $498,361 on 29 April 2024.
The largest trade he's ever made was exercising 3,079 units of Labcorp stock on 27 March 2024 worth over $672,115. On average, Peter trades about 609 units every 59 days since 2020. As of 29 April 2024 he still owns at least 2,087 units of Labcorp stock.
You can see the complete history of Mr. Wilkinson stock trades at the bottom of the page.
Peter J. Wilkinson serves as Senior Vice President, Chief Accounting Officer of the Company. From January 2019 until then, Mr. Wilkinson served in the role of LabCorp’s Senior Vice President, Accounting. Prior to that, Mr. Wilkinson served as Executive Vice President and Chief Financial Officer of Syneos Health, Inc.’s clinical division, a biopharmaceuticals services organization, from August 2017 to July 2018 and as Senior Vice President and Chief Accounting Officer of INC Research Holdings, Inc., a publicly traded predecessor to Syneos Health, from February 2016 to August 2017. Mr. Wilkinson also previously served as Senior Vice President in the INC Research finance department from April 2014 to February 2016. Prior to his position with INC Research, Mr. Wilkinson worked as a self-employed financial consultant, following earlier positions as the Chief Accounting Officer at Pharmaceutical Product Development, LLC, a clinical research organization and an auditor with Deloitte.
Peter Wilkinson is 49, he's been the Senior Vice President és Chief Accounting Officer of Labcorp since 2019. There are 22 older and 3 younger executives at Labcorp. The oldest executive at Labcorp Holdings Inc. is Jean-Luc Belingard, 71, who is the Independent Director.
Over the last 19 years, insiders at Labcorp have traded over $236,972,149 worth of Labcorp stock and bought 10,666 units worth $1,520,331 . The most active insiders traders include Mahon Thomas P Mac, Garheng Kong és David P King. On average, Labcorp executives and independent directors trade stock every 11 days with the average trade being worth of $2,652,442. The most recent stock trade was executed by Der Vaart Sandra D Van on 19 August 2024, trading 2,000 units of LH stock currently worth $454,100.
recognized for our innovation, quality, and customer convenience, labcorp delivers timely, accurate results for improved patient care. with scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, labcorp performs more than one million tests on approximately 400,000 samples each day. labcorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. labcorp operates a sophisticated laboratory network, with corporate headquarters in burlington, nc, and more than 34,000 employees worldwide. our more than 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. laboratory corporation of america holdings is listed on the new york stock exchange (nyse) under ticker symbol lh.
Labcorp executives and other stock owners filed with the SEC include: